Anemia in patients with HS is a multifaceted condition often driven by iron deficiency and chronic inflammation. Understanding the roles of hepcidine, iron kidnapping and suppression of bone marrow is crucial to develop effective treatment plans. When addressing the underlying causes, including the management of chronic infections such as staphylis A, patients can improve their quality of life and reduce the impact of anemia on their general health.
By raising awareness of the connections between HS, anemia and infections, we can help people who live with HS to better understand their condition and work towards more effective treatments.
